Although modern specialty-based medicine attempts to break down disease processes into manageable systems, many patients present with multiple comorbidities. This is particularly true of the cardiorespiratory system. Some of the major risk factors for heart and lung disease are common to both (e.g., smoking and advanced age). In addition, chronic respiratory disease can lead to pulmonary arterial hypertension and right ventricular failure. Left ventricular dysfunction contributes to dyspnea and may result in pulmonary edema. In many patients, it can be difficult to tease out the cardiovascular and respiratory contributions to breath-lessness and exercise intolerance and provide appropriate treatment. This heart-lung interface is the realm of cardiopulmonary medicine.
In this series of reviews, a number of leading experts provide an update on the diagnosis and treatment of pulmonary arterial hypertension, cor pulmonale, chronic heart failure and the lung, chronic thromboembolic disease, and the relationship between chronic obstructive pulmonary disease and cardiovascular morbidity. These reviews show that cardiopulmonary medicine is a rapidly advancing area for therapy and clinical research with major relevance to the respiratory physician and cardiologist alike.
